![Barry Gertz](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Barry Gertz
Private Equity Investor at BLACKSTONE INC.
Profile
Barry J.
Gertz is currently a Director at Cytel, Inc., a Managing Director at Blackstone, Inc., and a Consultant in Drug Development at Twin Bridges Life Sciences LLC.
Previously, he held positions as a Director at Cytel, Inc., an Independent Director at Sesen Bio, Inc., and as the Senior VP & Head-Global Clinical Development at Merck & Co., Inc. from 1986 to 2014.
He was also a Member of the Scientific Advisory Board at HealthCare Ventures LLC from 2010 to 2013, and a Venture Partner at Clarus Ventures LLC from 2014 to 2018.
Dr. Gertz obtained his undergraduate and doctorate degrees from the University of Pennsylvania and a doctorate degree from Perelman School of Medicine.
Latest news about Barry Gertz
Barry Gertz active positions
| Companies | Position | Start |
|---|---|---|
| BLACKSTONE INC. | Private Equity Investor | 31/12/2018 |
Twin Bridges Life Sciences LLC | Consultant / Advisor | 06/01/2014 |
Cytel, Inc.
 Cytel, Inc. Packaged SoftwareTechnology Services Provides statistical software and analytic services for clinical trials | Director/Board Member | - |
Blackstone Life Sciences Advisors LLC
 Blackstone Life Sciences Advisors LLC Blackstone Life Sciences invests in companies located across the globe. The firm targets companies operating in the fields on pharmaceutical, biotechnology and medical technology sectors. It provides financing for growth stage transactions. | Private Equity Investor | - |
Former positions of Barry Gertz
| Companies | Position | End |
|---|---|---|
Clarus Ventures LLC
 Clarus Ventures LLC Investment ManagersFinance Clarus Ventures invests in companies located in the United States. The firm focuses on companies operating in the fields of biopharmaceutical and medical technology. It participates in early stage capital transactions. Clarus Ventures acquired by Blackstone Inc on November 30, 2018. Clarus ventures will become Blackstone Life Sciences. | Private Equity Investor | 11/01/2018 |
| MERCK & CO., INC. | Corporate Officer/Principal | 30/06/2014 |
HealthCare Ventures LLC
 HealthCare Ventures LLC Investment ManagersFinance HealthCare Ventures invests in companies located in the United States. The firm target companies operating in the fields of life sciences, pharmaceuticals and biotechnology. It provides financing for early and later stage capital requirements. | Consultant / Advisor | 31/12/2012 |
Cytel, Inc.
Cytel, Inc. Packaged SoftwareTechnology Services Provides statistical software and analytic services for clinical trials | Director/Board Member | - |
| CARISMA THERAPEUTICS, INC. | Director/Board Member | - |
Training of Barry Gertz
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 10 |
|---|---|
Merck & Co., Inc.
 Merck & Co., Inc. Manufactures human and animal health pharmaceutical products & vaccines | |
Cytel, Inc.
Cytel, Inc. Packaged SoftwareTechnology Services Provides statistical software and analytic services for clinical trials | Technology Services |
HealthCare Ventures LLC
HealthCare Ventures LLC Investment ManagersFinance HealthCare Ventures invests in companies located in the United States. The firm target companies operating in the fields of life sciences, pharmaceuticals and biotechnology. It provides financing for early and later stage capital requirements. | Finance |
University of Pennsylvania
 University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Clarus Ventures LLC
Clarus Ventures LLC Investment ManagersFinance Clarus Ventures invests in companies located in the United States. The firm focuses on companies operating in the fields of biopharmaceutical and medical technology. It participates in early stage capital transactions. Clarus Ventures acquired by Blackstone Inc on November 30, 2018. Clarus ventures will become Blackstone Life Sciences. | Finance |
Blackstone, Inc.
 Blackstone, Inc. Investment ManagersFinance Provides investment and fund management services | Finance |
Sesen Bio, Inc.
 Sesen Bio, Inc. Pharmaceuticals: MajorHealth Technology Develops protein therapeutics to treat eye diseases | Health Technology |
Perelman School of Medicine
 Perelman School of Medicine Functions as a College/University | |
Blackstone Life Sciences Advisors LLC
Blackstone Life Sciences Advisors LLC Blackstone Life Sciences invests in companies located across the globe. The firm targets companies operating in the fields on pharmaceutical, biotechnology and medical technology sectors. It provides financing for growth stage transactions. | |
Twin Bridges Life Sciences LLC |
- Stock Market
- Insiders
- Barry Gertz
